Recursion Pharmaceuticals expanded its collaboration with Citeline to integrate real world data into its AI enabled ClinTech Platform. The partnership is aimed at refining clinical trial design and ...
In March 2026, Citeline announced an expanded strategic partnership with Recursion Pharmaceuticals to integrate Citeline's real-world data and evidence into Recursion’s tech-enabled drug discovery and ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost its shares, per Goldman Sachs.
We need major publicity to get across a matter of etiquette for concert and theater attendees: WAIT UNTIL THE CURTAIN CALL IS ...
Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman, M.D., will become Recursion’s Chief Medical Officer ...
Holding signs and banners reading Stop the AI Race and Don’t Build Skynet, the protesters marched through the city and gave ...
Generic formats like JSON or XML are easier to version than forms. However, they were not originally intended to be ...
New programming expands hospitality model and diversifies revenue streams amid shifting direct-to-consumer landscape. April 1 ...
Silicon Valley’s timeline for "solving" human health is dangerously optimistic, but AI is quietly breaking pharma’s biggest ...
Arka Mazumder hails from a middle-class family and had to also take education loans. Now, however, with a lucrative job, he ...
For direct API integration and via third-party provider OpenRouter, MiniMax M2.7 maintains a cost-leading price point of 0.30 dollars per 1 million input tokens and 1.20 dollars per 1 million output ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results